MB
Munera Maria E Bedoya-Toro
SVP, Regulatory Affairs

Munera Maria E Bedoya-Toro insider trades: Dermata Therapeutics (DRMA) stock buys and sales

SVP, Regulatory Affairs, Dermata Therapeutics Last trade Feb 17, 2026 25 Form 4 filings
$0
Sold, last 12 months
0 sales
$1K
Bought, last 12 months
1 buy
10
Open-market trades
since 2013
2
Companies
last trade 2026

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Munera reports to the SEC

Open-market buys and sales

10 trades reported on SEC Form 4, newest first

DateStockTypeValue
Feb 17, 2026DRMA↑ Buy$1K
Oct 8, 2013SNTS↓ Sell$214K
Sep 9, 2013SNTS↓ Sell$225K
Aug 8, 2013SNTS↓ Sell$274K
Jul 8, 2013SNTS↓ Sell$233K
Jun 10, 2013SNTS↓ Sell$216K
May 8, 2013SNTS↓ Sell$205K
Apr 8, 2013SNTS↓ Sell$167K
Mar 8, 2013SNTS↓ Sell$155K
Feb 8, 2013SNTS↓ Sell$130K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

Other DRMA insiders

Open-market trades in the last 12 months

About Munera Maria E Bedoya-Toro's insider trades

Munera Maria E Bedoya-Toro is SVP, Regulatory Affairs at Dermata Therapeutics (DRMA). Since Feb 8, 2013, Munera has reported 1 open-market purchase worth $1K and 9 sales worth $1.8M on SEC Form 4. In the last 12 months: 1 buy ($1K).

Their filings also include grants and awards (14 filings), option exercises (10 filings), conversions (1 filing), shares returned to the company (1 filing). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every DRMA insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.